A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer ; volume:14 ; number:1 ; day:30 ; month:3 ; year:2014 ; pages:1-9 ; date:12.2014
BMC cancer ; 14, Heft 1 (30.3.2014), 1-9, 12.2014
- Urheber
-
Lerouge, Delphine
- Beteiligte Personen und Organisationen
-
Rivière, Alain
Dansin, Eric
Chouaid, Christos
Dujon, Cécile
Schott, Roland
Lavole, Armelle
Le Pennec, Vincent
Fabre, Elizabeth
Crequit, Jacky
Martin, Francis
Dehette, Stéphanie
Fournel, Pierre
Precheur-Agulhon, Bénédicte
Lartigau, Eric
Zalcman, Gerard
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-231
- URN
-
urn:nbn:de:1111-2016030420327
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lerouge, Delphine
- Rivière, Alain
- Dansin, Eric
- Chouaid, Christos
- Dujon, Cécile
- Schott, Roland
- Lavole, Armelle
- Le Pennec, Vincent
- Fabre, Elizabeth
- Crequit, Jacky
- Martin, Francis
- Dehette, Stéphanie
- Fournel, Pierre
- Precheur-Agulhon, Bénédicte
- Lartigau, Eric
- Zalcman, Gerard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line
Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer : long-term results
Chromatin Regulates Genome Targeting with Cisplatin
Chromatin Regulates Genome Targeting with Cisplatin
Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Chromatin remodeling-driven autophagy activation induces cisplatin resistance in oral squamous cell carcinoma
Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line
Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer : long-term results
Chromatin Regulates Genome Targeting with Cisplatin
Chromatin Regulates Genome Targeting with Cisplatin
Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
Chromatin remodeling-driven autophagy activation induces cisplatin resistance in oral squamous cell carcinoma
Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line
Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer : long-term results
Chromatin Regulates Genome Targeting with Cisplatin
Chromatin Regulates Genome Targeting with Cisplatin
Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer